Hudock Inc. lessened its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 4.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 3,038 shares of the company’s stock after selling 151 shares during the period. Hudock Inc.’s holdings in Colgate-Palmolive were worth $276,000 at the end of the most recent quarter.
Other hedge funds have also recently modified their holdings of the company. Union Bancaire Privee UBP SA purchased a new stake in shares of Colgate-Palmolive in the 4th quarter worth approximately $32,000. Hager Investment Management Services LLC purchased a new position in shares of Colgate-Palmolive in the fourth quarter worth $36,000. Reston Wealth Management LLC purchased a new position in shares of Colgate-Palmolive in the third quarter worth $42,000. Capital Performance Advisors LLP purchased a new position in shares of Colgate-Palmolive in the third quarter worth $53,000. Finally, Synergy Asset Management LLC purchased a new position in shares of Colgate-Palmolive in the fourth quarter worth $49,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Stock Performance
CL opened at $86.75 on Thursday. The firm’s fifty day simple moving average is $90.00 and its two-hundred day simple moving average is $96.61. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. The company has a market cap of $70.88 billion, a price-to-earnings ratio of 24.64, a PEG ratio of 4.12 and a beta of 0.44. Colgate-Palmolive has a 52-week low of $82.76 and a 52-week high of $109.30.
Colgate-Palmolive Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.31%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 56.82%.
Analyst Ratings Changes
A number of analysts have recently weighed in on CL shares. UBS Group cut their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Piper Sandler dropped their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Stifel Nicolaus dropped their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research report on Monday, February 3rd. Finally, JPMorgan Chase & Co. dropped their price target on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive has an average rating of “Hold” and an average target price of $101.16.
Check Out Our Latest Research Report on Colgate-Palmolive
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Insider Trades May Not Tell You What You Think
- Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial
- The How And Why of Investing in Oil Stocks
- Double-Digit Gains Ahead? These 2 Cybersecurity Stocks Look Ready
- 3 Warren Buffett Stocks to Buy Now
- Will Falling Bond Yields Send These 2 Small Caps Soaring?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.